Patients with osteoporosis: children of a lesser god. Issue 1 (9th February 2023)

• Record Type: Journal Article
• Authors: Adami, Giovanni; Tsourdi, Elena; Rossini, Maurizio; Funck-Brentano, Thomas; Chapurlat, Roland
• Is Part Of: RMD open. Volume 9:Issue 1(2023)
• Publication Date: 2023-02-09
• Subjects: Osteoporosis -- Outcome Assessment, Health Care -- Outcome and Process Assessment, Health Care; Musculoskeletal system -- Diseases -- Periodicals; Rheumatism -- Periodicals; 616.7005
• DOI: 10.1136/rmdopen-2022-002973
• Languages: English
• ISSNs: 2056-5933

Abstract

Abstract : Osteoporosis is a common non-communicable disease with enormous societal costs. Antiosteoporosis medications have been proven efficacious in reducing the refracture rate and mortality; moreover, we have now convincing evidence about the cost-effectiveness of antiosteoporotic medications. However, albeit preventable and treatable, osteoporosis has been somehow neglected by health authorities. Drugs approval has been unnecessarily lengthy, especially when compared with other non-communicable diseases. Herein, we discuss the issue of procrastinating drug approval in osteoporosis and future implications.